Repare Therapeutics Inc
NASDAQ:RPTX
Repare Therapeutics Inc
NASDAQ:RPTX
Price:
2.65
USD
Market Cap:
$113.9m
Income Statement
Earnings Waterfall
Repare Therapeutics Inc
Repare Therapeutics Inc
Income Statement
Repare Therapeutics Inc
Repare Therapeutics Inc
Currency: USD
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+200%
|
1
+100%
|
1
+50%
|
8
+744%
|
8
+4%
|
8
+5%
|
121
+1 352%
|
132
+9%
|
137
+4%
|
167
+22%
|
56
-66%
|
51
-9%
|
98
+91%
|
69
-30%
|
67
-3%
|
53
-20%
|
1
-98%
|
0
-77%
|
12
+4 648%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(26)
|
(32)
|
(39)
|
(47)
|
(54)
|
(65)
|
(80)
|
(98)
|
(116)
|
(130)
|
(142)
|
(149)
|
(152)
|
(157)
|
(160)
|
(161)
|
(167)
|
(169)
|
(165)
|
(159)
|
(146)
|
(132)
|
(114)
|
(91)
|
|
| Selling, General & Administrative |
(5)
|
(7)
|
(9)
|
(12)
|
(13)
|
(17)
|
(20)
|
(22)
|
(26)
|
(30)
|
(31)
|
(32)
|
(32)
|
(32)
|
(33)
|
(33)
|
(34)
|
(34)
|
(33)
|
(32)
|
(30)
|
(29)
|
(26)
|
(25)
|
|
| Research & Development |
(21)
|
(26)
|
(30)
|
(35)
|
(39)
|
(48)
|
(59)
|
(75)
|
(89)
|
(100)
|
(111)
|
(117)
|
(117)
|
(124)
|
(127)
|
(128)
|
(132)
|
(135)
|
(131)
|
(127)
|
(116)
|
(103)
|
(87)
|
(67)
|
|
| Depreciation & Amortization |
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(26)
N/A
|
(32)
-23%
|
(39)
-21%
|
(47)
-19%
|
(54)
-15%
|
(65)
-22%
|
(80)
-22%
|
(97)
-22%
|
(109)
-12%
|
(122)
-12%
|
(134)
-10%
|
(29)
+78%
|
(20)
+31%
|
(20)
+1%
|
7
N/A
|
(105)
N/A
|
(116)
-11%
|
(71)
+39%
|
(95)
-35%
|
(92)
+4%
|
(92)
0%
|
(131)
-42%
|
(114)
+13%
|
(79)
+30%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(2)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
1
|
3
|
6
|
9
|
12
|
13
|
13
|
13
|
12
|
11
|
10
|
9
|
7
|
7
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
1
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(1)
|
(5)
|
(2)
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Pre-Tax Income |
(27)
N/A
|
(35)
-29%
|
(40)
-16%
|
(46)
-15%
|
(55)
-19%
|
(64)
-16%
|
(79)
-24%
|
(97)
-23%
|
(109)
-12%
|
(122)
-12%
|
(133)
-9%
|
(26)
+80%
|
(14)
+47%
|
(11)
+24%
|
19
N/A
|
(92)
N/A
|
(103)
-12%
|
(58)
+44%
|
(83)
-44%
|
(82)
+2%
|
(83)
-2%
|
(126)
-52%
|
(109)
+14%
|
(71)
+34%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
3
|
2
|
2
|
1
|
0
|
(15)
|
(19)
|
(22)
|
(5)
|
9
|
12
|
15
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
(27)
|
(35)
|
(40)
|
(47)
|
(53)
|
(62)
|
(77)
|
(94)
|
(107)
|
(120)
|
(132)
|
(26)
|
(29)
|
(29)
|
(3)
|
(97)
|
(94)
|
(46)
|
(69)
|
(84)
|
(85)
|
(128)
|
(110)
|
(72)
|
|
| Net Income (Common) |
(27)
N/A
|
(35)
-29%
|
(40)
-15%
|
(47)
-15%
|
(53)
-15%
|
(62)
-17%
|
(77)
-23%
|
(94)
-22%
|
(107)
-14%
|
(120)
-13%
|
(132)
-10%
|
(26)
+81%
|
(29)
-13%
|
(29)
-1%
|
(3)
+90%
|
(97)
-3 147%
|
(94)
+4%
|
(46)
+51%
|
(69)
-50%
|
(84)
-22%
|
(85)
0%
|
(128)
-51%
|
(110)
+14%
|
(72)
+34%
|
|
| EPS (Diluted) |
-0.78
N/A
|
-1
-28%
|
-1.09
-9%
|
-1.26
-16%
|
-1.45
-15%
|
-1.68
-16%
|
-2.07
-23%
|
-2.53
-22%
|
-2.83
-12%
|
-2.87
-1%
|
-3.15
-10%
|
-0.58
+82%
|
-0.69
-19%
|
-0.69
N/A
|
-0.07
+90%
|
-2.31
-3 200%
|
-2.23
+3%
|
-1.04
+53%
|
-1.64
-58%
|
-2
-22%
|
-2
N/A
|
-3.01
-50%
|
-2.55
+15%
|
-1.69
+34%
|
|
Switch to:
Switch to:
See Also
Discover More
